✦ LIBER ✦

A one-year prospective study of the safety, tolerability and pharmacokinetics of the highest available dose of paliperidone palmitate in patients with schizophrenia

✍ Scribed by Danielle Coppola, Yanning Liu, Srihari Gopal, Bart Remmerie…

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A 52-week open-label study of the safety

✍ Gopal, S.; Vijapurkar, U.; Lim, P.; Morozova, M.; Eerdekens, M.; Hough, D. 📂 Article 📅 2010 🏛 SAGE Publications 🌐 English ⚖ 288 KB

1096 – Safety, tolerability and treatmen

✍ Schreiner, A.; Hargarter, L.; Bergmans, P.; Cherubin, P. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 French ⚖ 43 KB

EPA-1550 - Paliperidone palmitate in acu

✍ Schreiner, A.; Bergmans, P.; Cherubin, P.; Rancans, E.; Bez, Y.; Parellada, E.; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 French ⚖ 68 KB

1100 – Safety, tolerability and treatmen

✍ Schreiner, A.; Hargarter, L.; Bergmans, P.; Cherubin, P. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 French ⚖ 43 KB

Poster #T210 PALIPERIDONE PALMITATE IN A

✍ Schreiner, Andreas; Bergmans, Paul; Cherubin, Pierre; Rancans, Elmars; Bez, Yasi 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 92 KB

P.3.d.014 Efficacy and safety of paliper

✍ Wakamatsu, A.; Takahashi, N.; Takahashi, M.; Saito, T.; Iizumi, M.; Saito, Y.; S 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 57 KB